Large Cystic Intracardiac Mass Overlying Left Atrial Appendage Occlusion Device: A Case Report and Literature Review

Overview

Journal CASE (Phila)

Specialty Cardiology & Vascular Diseases

Date 2021 Mar 1

PMID 33644507

Citations 1

Authors

Abdulaziz Joury

Nadia Abelhad

Jayna Kelly

Francis Benn

Joseph A R Englert 3rd

Affiliations

Soon will be listed here.

Citing Articles

Emerging Concepts on Infection of Novel Cardiac Implantable Devices.

Ramadan M, Gallo R, Patauner F, Bertolino L, Durante-Mangoni E Rev Cardiovasc Med. 2024; 23(8):277.

PMID: 39076625 PMC: 11266971. DOI: 10.31083/j.rcm2308277.

References

Grygier M, Olasinska-Wisniewska A, Araszkiewicz A, Trojnarska O, Babicz-Sadowska A, Lesiak M . The Watchman FLX - a new device for left atrial appendage occlusion - design, potential benefits and first clinical experience. Postepy Kardiol Interwencyjnej. 2017; 13(1):62-66. PMC: 5364284. DOI: 10.5114/aic.2017.66188. View

Vainrib A, Harb S, Jaber W, Benenstein R, Aizer A, Chinitz L . Left Atrial Appendage Occlusion/Exclusion: Procedural Image Guidance with Transesophageal Echocardiography. J Am Soc Echocardiogr. 2017; 31(4):454-474. DOI: 10.1016/j.echo.2017.09.014. View

Alkhouli M, Busu T, Shah K, Osman M, Alqahtani F, Raybuck B . Incidence and Clinical Impact of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion: A Meta-Analysis. JACC Clin Electrophysiol. 2018; 4(12):1629-1637. DOI: 10.1016/j.jacep.2018.09.007. View

Reddy V, Holmes D, Doshi S, Neuzil P, Kar S . Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation. 2011; 123(4):417-24. DOI: 10.1161/CIRCULATIONAHA.110.976449. View

Holmes Jr D, Kar S, Price M, Whisenant B, Sievert H, Doshi S . Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014; 64(1):1-12. DOI: 10.1016/j.jacc.2014.04.029. View

Naccarelli G, Varker H, Lin J, Schulman K . Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009; 104(11):1534-9. DOI: 10.1016/j.amjcard.2009.07.022. View

Blackshear J, ODell J . Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996; 61(2):755-9. DOI: 10.1016/0003-4975(95)00887-X. View

Holmes D, Reddy V, Turi Z, Doshi S, Sievert H, Buchbinder M . Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009; 374(9689):534-42. DOI: 10.1016/S0140-6736(09)61343-X. View

Baddour L, Wilson W, Bayer A, Fowler Jr V, Tleyjeh I, Rybak M . Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015; 132(15):1435-86. DOI: 10.1161/CIR.0000000000000296. View

10.

Jensen J, Thaler C, Saxena R, Calcaterra D, Sanchez J, Orlandi Q . Transesophageal Echocardiography to Diagnose Watchman Device Infection. CASE (Phila). 2020; 4(3):189-194. PMC: 7303240. DOI: 10.1016/j.case.2020.01.008. View